Kinetics of SARS-CoV-2 antibody responses pre-COVID-19 and post-COVID-19 convalescent plasma transfusion in patients with severe respiratory failure: an observational case-control study

Conclusions
CCP transfusion did not increase the kinetics of SARS-CoV2 antibodies and did not result in improved clinical outcomes in patients with COVID-19 with severe respiratory failure, suggesting that CCP may not be indicated in this category of patients.

Source: Journal of Clinical Pathology - July 19, 2022 Category: Pathology Authors: Klein, M. N., Wang, E. W., Zimand, P., Beauchamp, H., Donis, C., Ward, M. D., Martinez-Hernandez, A., Tabatabai, A., Baddley, J. W., Bloch, E. M., Mullins, K. E., Fontaine, M. J. Tags: Open access, COVID-19 Original research Source Type: research